The MRC1/CD68 Ratio Is Positively Associated with Adipose Tissue Lipogenesis and with Muscle Mitochondrial Gene Expression in Humans

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Moreno Navarrete, José María ^a   Ortega, Francisco ^a   Gómez Serrano, María ^b   García Santos, Eva ^b   Ricart, Wifredo ^a   Tinahones, Francisco ^c   Mingrone, Geltrude ^d   Peral, Belén ^b   Fernández Real, José Manuel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD206 ANTIGEN; CD68 ANTIGEN; GLUCOSE; INSULIN RECEPTOR SUBSTRATE 1; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ACACA GENE; ADIPOSE TISSUE; ADULT; ARTICLE; BARIATRIC SURGERY; BODY FAT; BODY MASS; CAUCASIAN; CD206 GENE; CD68 GENE; CONTROLLED STUDY; DIET RESTRICTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; END TO SIDE ANASTOMOSIS; FASN GENE; FEMALE; GASTRECTOMY; GENE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRS1 GENE; LIPOGENESIS; LONGITUDINAL STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL GENE; MORBID OBESITY; MT CO3 GENE; MUSCLE MITOCHONDRION; PPARGC1A GENE; RECTUS ABDOMINIS MUSCLE; SUBCUTANEOUS FAT; TFAM GENE; THRSP GENE; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; FEMALE; GENE EXPRESSION REGULATION; GENES, MITOCHONDRIAL; HUMANS; LECTINS, C-TYPE; LIPOGENESIS; MALE; MANNOSE-BINDING LECTINS; MIDDLE AGED; MITOCHONDRIA, MUSCLE; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; SUBCUTANEOUS FAT; TRANSCRIPTOME; WEIGHT LOSS;

EID: 84881537336     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070810     Document Type: Article

References (41)

1. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
2. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830.
3. Curat CA, Miranville A, Sengenès C, Diehl M, Tonus C, et al. (2004) From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53: 1285-1292.
4. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, et al. (2005) Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54: 2277-2286.
5. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
6. Gordon S, (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35.
7. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549 -555.
8. Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, et al. (2009) Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58: 2574-2582.
9. Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, Hugol D, et al. (2009) Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 94: 4619-4623.
10. Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, et al. (2008) Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages. Circulation 117: 806-815.
11. Prieur X, Mok CY, Velagapudi VR, Núñez V, Fuentes L, et al. (2011) Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes 60: 797-809.
12. Hutchison SK, Teede HJ, Rachoń D, Harrison CL, Strauss BJ, et al. (2012) Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome. Diabetologia 55: 1424-1434.
13. Gastaldi G, Russell A, Golay A, Giacobino JP, Habicht F, et al. (2007) Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure. Diabetologia 50: 2348-2355.
14. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, et al. (2003) Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 52: 1888-1896.
15. Holmström MH, Iglesias-Gutierrez E, Zierath JR, Garcia-Roves PM, (2012) Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes. Am J Physiol Endocrinol Metab 302: E731-E739.
16. Chung N, Kreutz T, Schiffer T, Opitz D, Hermann R, et al. (2012) Training-induced alterations of skeletal muscle mitochondrial biogenesis proteins in non-insulin-dependent type 2 diabetic men. Can J Physiol Pharmacol 90: 1634-1641.
17. Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, et al. (2006) Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55: 2025-2031.
18. Stienstra R, Duval C, Keshtkar S, van der Laak J, Kersten S, et al. (2008) Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue. J Biol Chem 283: 22620-22627.
19. Arner P, Arner E, Hammarstedt A, Smith U, (2011) Genetic predisposition for Type 2 diabetes, but not for overweight/obesity, is associated with a restricted adipogenesis. PLoS One 6: e18284.
20. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, et al. (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637.
21. Virtue S, Vidal-Puig A, (2010) Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome - an allostatic perspective. Biochim Biophys Acta 1801: 338-349.
22. Masgrau A, Mishellany-Dutour A, Murakami H, Beaufrère AM, Walrand S, et al. (2012) Time-course changes of muscle protein synthesis associated with obesity-induced lipotoxicity. J Physiol 590: 5199-5210.
23. Patel SA, Hoehn KL, Lawrence RT, Sawbridge L, Talbot NA, et al. (2012) Overexpression of the Adiponectin Receptor AdipoR1 in Rat Skeletal Muscle Amplifies Local Insulin Sensitivity. Endocrinology 153: 5231-5246.
24. Mullen KL, Pritchard J, Ritchie I, Snook LA, Chabowski A, et al. (2009) Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am J Physiol Regul Integr Comp Physiol 296: R243-R251.
25. Liu Y, Turdi S, Park T, Morris NJ, Deshaies Y, et al. (2013) Adiponectin corrects high-fat diet-induced disturbances in muscle metabolomic profile and whole-body glucose homeostasis. Diabetes 62: 743-752.
26. Qiao L, Kinney B, Yoo HS, Lee B, Schaack J, et al. (2012) Adiponectin increases skeletal muscle mitochondrial biogenesis by suppressing mitogen-activated protein kinase phosphatase-1. Diabetes 61: 1463-1470.
27. Civitarese AE, Ukropcova B, Carling S, Hulver M, DeFronzo RA, et al. (2006) Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab 4: 75-87.
28. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang Cc, et al. (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A 99: 16309-16313.
29. Shimabukuro M, Hirata Y, Tabata M, Dagvasumberel M, Sato H, et al. (2013) Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 33: 1077-1084.
30. Pedersen BK, Febbraio MA, (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8: 457-465.
31. Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, et al. (2006) IL-6 increases insulin stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMPK. Diabetes 55: 2688-2697.
32. Quinn LS, Anderson BG, Strait-Bodey L, Stroud AM, Argilés JM, (2009) Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab 296: E191-202.
33. Barra NG, Reid S, MacKenzie R, Werstuck G, Trigatti BL, et al. (2010) Interleukin-15 contributes to the regulation of murine adipose tissue and human adipocytes. Obesity 18: 1601-1607.
34. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, et al. (2012) A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481: 463-468.
35. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, et al. (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 98: E769-E778.
36. Sun K, Kusminski CM, Scherer PE, (2011) Adipose tissue remodeling and obesity. J Clin Invest 121: 2094-2101.
37. Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, et al. (2010) Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 59: 1648-1656.
38. Klöting N, Fasshauer M, Dietrich A, Kovacs P, Schön MR, et al. (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299: E506-E515.
39. Preis SR, Massaro JM, Robins SJ, Hoffmann U, Vasan RS, et al. (2010) Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity 18: 2191-2198.
40. Ortega FJ, Mayas D, Moreno-Navarrete JM, Catalán V, Gómez-Ambrosi J, et al. (2010) The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity 18: 13-20.
41. Veilleux A, Blouin K, Rhéaume C, Daris M, Marette A, et al. (2009) Glucose transporter 4 and insulin receptor substrate-1 messenger RNA expression in omental and subcutaneous adipose tissue in women. Metabolism 58: 624-631.